Clarendon Private’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
6,297
+698
+12% +$163K 1.18% 19
2025
Q4
$1.16M Buy
5,599
+1,407
+34% +$278K 0.98% 25
2025
Q3
$777K Buy
+4,192
New +$718K 0.71% 39
2025
Q2
Sell
-1,637
Closed -$272K 104
2025
Q1
$272K Sell
1,637
-271
-14% -$42.4K 0.29% 88
2024
Q4
$276K Buy
+1,908
New +$296K 0.29% 84

Other funds holding JNJ

Clarendon Private's JNJ Position: Q1 2026 in Review

Clarendon Private increased its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, buying an estimated $163K and bringing the position to 6,297 shares worth $1.54M. The position accounts for 1.18% of the portfolio, ranked #19.

Clarendon Private first reported a position in JNJ in Q4 2024 and has held it in 5 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Clarendon Private held 6,297 shares of Johnson & Johnson worth $1.54M as of Q1 2026.
  • Clarendon Private bought 698 Johnson & Johnson shares in Q1 2026, an estimated $163K.
  • Johnson & Johnson made up 1.18% of Clarendon Private's portfolio in Q1 2026, its #19 holding.
  • Clarendon Private first reported a position in Johnson & Johnson in Q4 2024 and has held it in 5 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Clarendon Private's 13F filing for Q1 2026, filed 11 May 2026.